Hi-Tech Pharmacal Receives Warning Letter From FDA On Certain OTC Products

(RTTNews) - Specialty pharmaceutical company, Hi-Tech Pharmacal Co., Inc. (HITK), a maker of generic and branded prescription and OTC products ,Wednesday said its Health Care Products Over The Counter division received a Warning letter from the US Food and Drug Administration on certain products, which had net sales of about $1 million in fiscal 2013. The FDA letter is related to the labeling of Diabeti-Derm Antifungal Cream, Zostrix Diabetic Foot Pain Relief Cream and Zostrix Diabetic Joint & Arthritis Pain Relief Cream. The Health Care Product segment intends to fully agree to the requirements provided in the warning letter, the company said in a statement.